Catheter ablation and left ventricular recovery in patients with clinically diagnosed polymorphic ventricular tachycardia and heart failure: a retrospective cohort study

Background Left ventricular recovery is an important treatment objective in patients with polymorphic ventricular tachycardia (PMVT) and heart failure. We examined 6-month left ventricular ejection fraction (LVEF) after radiofrequency catheter ablation (RFCA) in a retrospective cohort with paired cardiac magnetic resonance (CMR) measurements. Methods This single-center cohort included 92 patients with a clinical PMVT diagnosis and heart failure; 53 received RFCA and 39 did not. The primary outcome was baseline-adjusted 6-month LVEF. Propensity-score overlap weighting included 18 baseline covariates. HC3 standard errors, 2,000 treatment-stratified bootstrap resamples, reduced and expanded covariate sets, and ridge regularization assessed estimate stability. Native T1, extracellular volume fraction (ECV), premature ventricular complex (PVC) burden, biomarkers, and clinical events were secondary or exploratory outcomes. Results LVEF increased by 6.73 ± 2.15 percentage points with RFCA and 2.80 ± 1.86 without RFCA. The adjusted between-group difference was 3.70 percentage points (95% CI, 2.71–4.70); the propensity-refitting bootstrap interval was 2.78–4.53. Estimates incorporating hypertension and mineralocorticoid receptor antagonist use or ridge regularization ranged from 3.68 to 3.74 percentage points. Adjusted differences were −16.48 ms (95% CI, −20.44 to −12.53) for native T1, −1.26 percentage points (95% CI, −1.54 to −0.99) for ECV, and −6.77 percentage points (95% CI, −8.02 to −5.51) for PVC burden (all P < 0.001). Ventricular arrhythmia recurrence occurred in 5/53 vs. 10/39 patients; each group had two recurrences after the day-210 landmark. Conclusions RFCA was associated with greater 6-month LVEF recovery and lower recorded mapping indices and PVC burden in this selected paired-CMR cohort. Clinical-event comparisons were descriptive. The retrospective design, treatment selection, and requirement for paired CMR restrict the interpretation of these associations.

Authors

Institutions

Publication Details

Journal
Frontiers in Cardiovascular Medicine
Published
2026-11-18
DOI
https://doi.org/10.3389/fcvm.2026.2014842
Primary Topic
Cardiac Arrhythmias and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Catheter ablation and left ventricular recovery in patients with clinically diagnosed polymorphic ventricular tachycardia and heart failure: a retrospective cohort study

Dongpo Zhao, Wanhua Cheng, Qian Feng
5 links
Frontiers in Cardiovascular Medicine
Cardiac Arrhythmias and Treatments
article

Catheter ablation and left ventricular recovery in patients with clinically diagnosed polymorphic ventricular tachycardia and heart failure: a retrospective cohort study

Dongpo Zhao, Wanhua Cheng, Qian Feng
article en

Abstract

Background Left ventricular recovery is an important treatment objective in patients with polymorphic ventricular tachycardia (PMVT) and heart failure. We examined 6-month left ventricular ejection fraction (LVEF) after radiofrequency catheter ablation (RFCA) in a retrospective cohort with paired cardiac magnetic resonance (CMR) measurements. Methods This single-center cohort included 92 patients with a clinical PMVT diagnosis and heart failure; 53 received RFCA and 39 did not. The primary outcome was baseline-adjusted 6-month LVEF. Propensity-score overlap weighting included 18 baseline covariates. HC3 standard errors, 2,000 treatment-stratified bootstrap resamples, reduced and expanded covariate sets, and ridge regularization assessed estimate stability. Native T1, extracellular volume fraction (ECV), premature ventricular complex (PVC) burden, biomarkers, and clinical events were secondary or exploratory outcomes. Results LVEF increased by 6.73 ± 2.15 percentage points with RFCA and 2.80 ± 1.86 without RFCA. The adjusted between-group difference was 3.70 percentage points (95% CI, 2.71–4.70); the propensity-refitting bootstrap interval was 2.78–4.53. Estimates incorporating hypertension and mineralocorticoid receptor antagonist use or ridge regularization ranged from 3.68 to 3.74 percentage points. Adjusted differences were −16.48 ms (95% CI, −20.44 to −12.53) for native T1, −1.26 percentage points (95% CI, −1.54 to −0.99) for ECV, and −6.77 percentage points (95% CI, −8.02 to −5.51) for PVC burden (all P < 0.001). Ventricular arrhythmia recurrence occurred in 5/53 vs. 10/39 patients; each group had two recurrences after the day-210 landmark. Conclusions RFCA was associated with greater 6-month LVEF recovery and lower recorded mapping indices and PVC burden in this selected paired-CMR cohort. Clinical-event comparisons were descriptive. The retrospective design, treatment selection, and requirement for paired CMR restrict the interpretation of these associations.

Frontiers in Cardiovascular MedicineVol. 13
Hebei North University (CN), Zhangjiakou Academy of Agricultural Sciences (CN)
Good health and well-being
Cardiac Arrhythmias and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon